Back to search

Article

The potential clinical utility of cell-free DNA for gastric cancer patients treated with nivolumab monotherapy

2023-01-30

Abstract excerpt

<h4>Background: </h4> To assess the potential clinical utility of cell-free DNA (cfDNA)-based biomarkers for identifying gastric cancer (GC) patients who benefit from nivolumab. <h4>Methods: </h4>: From 31 GC patients treated with nivolumab monotherapy (240mg/body, Bi-weekly) in 3 rd or later line setting, we prospectively collected blood samples at baseline and before the 3 rd dose. We compared cfDNA-based molec...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
25f94252-daec-5d8b-a71b-10ab69d64226
DOI
10.21203/rs.3.rs-2512025/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The potential clinical utility of cell-free DNA for gastric cancer patients treated with nivolumab monotherapyDOI 10.21203/rs.3.rs-2512025/v1
Pairwise analysis of plasma cell-free DNA before and after palliative second-line paclitaxel plus ramucirumab treatment in patients with metastatic gastric cancer.Semantic proximity
Multimodal analysis of cell-free DNA to improve early detection of gastric cancer.Semantic proximity
Circulating tumor DNA (ctDNA) as a biomarker of response to therapy in advanced Hepatocellular carcinoma treated with Nivolumab.Semantic proximity
Cell‑free DNA as a liquid biopsy for early detection of gastric cancer (Review)Semantic proximity
The predicting role of circulating tumor DNA landscape in gastric cancer patients treated with immune checkpoint inhibitorsSemantic proximity
Liquid Biopsy in Gastric Cancer: Analysis of Somatic Cancer Tissue Mutations in Plasma Cell-Free DNA for Predicting Disease State and Patient Survival.Semantic proximity
Identification of Potential Genomic Alterations Using Pan-Cancer Cell-Free DNA Next-Generation Sequencing in Patients With Gastric Cancer.Semantic proximity
Development and validation of a blood-based assay for gastric cancer early detection: A multidimensional analysis of cell-free DNA whole methylome sequencing—protocol for an observational, case‒control studySemantic proximity
Clinicopathological and molecular features of responders to nivolumab for patients with advanced gastric cancerSemantic proximity
Circulating tumor DNA predicts clinical benefits of immune checkpoint blockade in HER2-negative patients with advanced gastric cancerSemantic proximity
Plasma cell-free DNA as a sensitive biomarker for multi-cancer detection and immunotherapy outcomes predictionSemantic proximity
Genome-Scale Methylation Analysis of Circulating Cell-Free DNA in Gastric Cancer PatientsSemantic proximity
Select a neighboring publication to make it the new centre.